Join us for a live webinar–Transforming the Treatment Paradigm for Duchenne Muscular Dystrophy–presented by Dyne Therapeutics as part of our Community Webinar Series. Dyne is to present an overview of its FORCE platform and Duchenne drug development program to the Jett Foundation community, and then engage in a conversation to capture comments and feedback.
Dyne has shared information on these DMD data and clinical plans. To learn more, register for their upcoming webinar!
SVP, Global Medical Affairs
Prior to joining Dyne, Ash served as vice president and global head of medical affairs at Sarepta Therapeutics, Inc., where he built the company’s medical affairs organization.
Jett Foundation invites all members of the Duchenne community to attend our Community Webinar Series! This series is focused on topics tailored to help individuals and families impacted by Duchenne learn more about care, clinical trials, resources, and support. We are committed to providing these 1-hour presentations to empower individuals and families with the tools and resources needed to be their own best advocates.
Please contact firstname.lastname@example.org with any questions or if you’d like to become a future speaker at one of our community webinars. We look forward to having you participate in these virtual community engagement events!